Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

sargramostim 2Topotecan 2timcodar 1bempegaldesleukin 1Tissue Plasminogen Activator 1Radiotherapy 1Radiosurgery 1Paclitaxel 1Muromonab-CD3 1Irinotecan 1Interferon-alpha 1Immunization, Passive 1Gemcitabine 1Docetaxel 1Diathermy 1Cyclophosphamide 1Cisplatin 1Captopril 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Unspecified Adult Solid Tumor, Protocol Specific × Muromonab-CD3 × Clear all
NCT00002482 2013-11-06

Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡